GLP-1 drugs were originally developed to treat type 2 diabetes, but several are now approved for chronic weight management: Wegovy (semaglutide), which is available as a pill or injection Zepbound (tirzepatide) injection Saxenda (liraglutide) injection Impact of Obesity on MS Progression Benefits of Weight Loss for People With MS Together, these findings suggest that weight loss may positively influence inflammation and symptoms relevant to MS, even though long-term effects on disease progression are still unclear, says Ali
It increased the production of NO, which is an anti-atherogenic molecule [37, 38]
GLP-1 patches are said to have ingredients that reduce appetite and cravings and manage blood sugar levels
T1DM, Type 1 diabetes mellitus
It compared nearly 216,000 people who were prescribed GLP-1 medications to people prescribed three other kinds of medications to lower their blood sugar, as well as those who enrolled in the system with diabetes who continued to take the medications they had already been prescribed without any changes to their therapy, meaning they didnt start a new drug during this time
A 26-week liraglutide study did not reduce amyloid levels or improve cognition, though it preserved how the brain uses glucose
